{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-284569","form_type":"8-K","ticker":"RLYB","cik":"0001739410","company_name":"Rallybio Corp","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.935587+00:00","generated_at":"2026-06-21T20:44:23.308917+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rallybio announces underwritten public offering of 5,000,001 shares at $6.00/share plus pre-funded warrants","bullets":["Offering of 5,000,001 shares of common stock at $6.00 per share and pre-funded warrants for 3,333,388 shares at $5.9999 each.","Underwriters granted 30-day option to purchase up to an additional 1,250,000 shares.","Pre-funded warrants have $0.0001 exercise price, are exercisable immediately, and do not expire.","Closing expected on or about November 15, 2022, subject to customary conditions.","J.P. Morgan, Cowen, and Evercore are joint book-running managers for the offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-284569","json":"https://secwatch.observer/filing/0001193125-22-284569.json","markdown":"https://secwatch.observer/filing/0001193125-22-284569.md","text":"https://secwatch.observer/filing/0001193125-22-284569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739410/000119312522284569/0001193125-22-284569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739410/000119312522284569/d407423d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T20:44:23.308917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fae11a7c4634187b61764033001daa05b16b95de","claim":"Rallybio Corp entered into Underwriting Agreement with J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C. (effective 2022-11-10).","evidence_excerpt":"On November 10, 2022, Rallybio Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., as representatives of the several underwriters named in Schedule A thereto (the “Underwriters”), relating to the underwritten offering of 5,000,001 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a price of $6.00 per Share, less the underwriting discounts and commissions, and, to certain investors in lieu of Common Stock, pre-funded warrants to purchase up to an aggregate of 3,333,388 shares of Common Stock at a price of $5.9999 (the “Pre-Funded Warrants”), which represents the per share public offering price for the Shares less the $0.0001 per share exercise price for each Pre-Funded Warrant (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739410/000119312522284569/0001193125-22-284569-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C."},{"label":"Effective","value":"2022-11-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}